Stem Cell Research
The Issue
One of the most promising areas of research in medical science today is the potential to use stem cells to better understand diseases and find treatments and cures. This research has become controversial because it involves the use of human embryos.
Our Position
Massbio opposes the use of cloning technology for the purpose of initiating and bringing to term a human pregnancy, commonly called human cloning.
We support therapeutic cloning, which is the use of cloning of human cells, genes and tissues for the purpose of medical research and for the treatments of such conditions as Parkinson's, multiple sclerosis, diabetes and spinal cord injuries.
We support President Obama's decision to overturn the federal stem cell funding ban in order to solve unmet medical needs around the globe.
About MassBio
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
Latest Updates
- February 3, 2012 BIO Buzz Builder - Worcester
- February 3, 2012 BSDM: An Innovative ADaM Programming Solution for Clinical Reporting & FDA Submission
- February 1, 2012 MassBio Coffee Break: Medford
- January 30, 2012 Annual Policy Breakfast Makes Headlines on Healthcare Reform
- January 27, 2012 BD: New VC Models for Early Stage Financing